Tessa Romero
Stock Analyst at JP Morgan
(1.96)
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
ACAD ACADIA Pharmaceutica... | Maintains: Overweight | 30 34 | 24.83 | 36.93% | 9 | Jul 24, 2025 | |
DYN Dyne Therapeutics | Maintains: Neutral | 10 9 | 11.23 | -19.86% | 6 | Jul 15, 2025 | |
BHVN Biohaven | Maintains: Overweight | 68 55 | 13.43 | 309.53% | 7 | Jun 18, 2025 | |
CYTK Cytokinetics | Maintains: Overweight | 71 53 | 33.2 | 59.64% | 5 | Jun 9, 2025 | |
LXEO Lexeo Therapeutics | Maintains: Overweight | 16 10 | 4.44 | 125.23% | 2 | May 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 38 | 16.6 | 128.92% | 1 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 18 15 | 1.44 | 941.67% | 4 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | n/a | n/a | n/a | 2 | Oct 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 18 31 | 31.47 | -1.49% | 5 | Oct 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 32 29 | 10.28 | 182.1% | 3 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 30 31 | 12.99 | 138.65% | 8 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Neutral | 46 | 35.1 | 31.05% | 6 | Jun 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 8 7 | 8.52 | -17.84% | 5 | Aug 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 54 55 | 34.12 | 61.2% | 2 | Apr 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 39 36 | n/a | n/a | 4 | Jun 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Overweight | 140 150 | 16.7 | 798.2% | 1 | Mar 2, 2021 |